Immunology of Bacille Calmette-Guérin and related topics

Clinical Infectious Diseases

Volumn 31, Issue SUPPL. 3, 2000, Pages

  Wittes, R C ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; DOXORUBICIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BCG VACCINATION; BLADDER CANCER; CANADA; CHILL; CLINICAL TRIAL; CONFERENCE PAPER; DRUG MECHANISM; DYSURIA; FEVER; HEMATURIA; HUMAN; IMMUNE RESPONSE; MALAISE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; TUBERCULOSIS; UNITED STATES;

ANIMALS; BCG VACCINE; HUMANS; TUBERCULOSIS, PULMONARY; URINARY BLADDER NEOPLASMS;

EID: 0034455083     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/314063     Document Type: Conference Paper

References (5)

1. Cancer and tuberculosis
2. Suppression of tumor growth at the site of infection with living bacillus Calmette-Guérin
3. Intracavitary Bacillus Calmette-Gúerin in the treatment of superficial bladder tumours
4. A randomized trial of intravesical doxorubicin and immunotherapy with Bacille Calmette-Guérin for transitional cell carcinoma of the bladder
5. Maintenance BCG immunotherapy in recurrent Ta, Tl, and carcinoma in situ transitional cell carcinoma: A randomized Southwest Oncology Group Study